The UV Foundation - Comment

STAKEHOLDER DRAFT GUIDANCE DOCUMENT PREPARED FOR FDA’S CONSIDERATION: Proposed Revision of CDRH Sunlamp Product Guidance Policy on Maximum Timer Interval and Exposure Schedule for Sunlamp Products, Submitted in Accordance with Good guidance practices, 21CFR §10.115(f)(4). Submitted electronically to Docket No. FDA–2007–N–0270 in accordance with Medical Device User Fee and Modernization Act; Notice to Public of Web Location of 2010 Proposed Guidance Development, Federal Register / Vol. 74, No. 201 / Tuesday, October 20, 2009 / Notices [FR Doc. E9–25179 Filed 10–19–09; 8:45 am]